Posts With Tag NASDAQ REGN

Showing 1 - 1 of 1 Post

Regeneron Pharmaceuticals 8-K Report: Latest Updates on Compliance & Stock Performance

•

Form 8-K

•

2025-06-18

Last updated: 4 months ago

Regeneron Pharmaceuticals 8-K Report: Latest Updates on Compliance & Stock Performance

Discover Regeneron Pharmaceuticals' June 13, 2025, 8-K filing, detailing key corporate events and stock info essential for investors.

Regeneron Pharmaceuticals biotechnology NASDAQ REGN 8-K filing investor relations